Investing in Flex Spending Accounts

This Stock is Set to Pop by January 1
By Ian Cooper
November 21, 2006

It's spend-it-or-lose-it time for millions of Americans who set aside funds for flex spending accounts. Any funds left in that account on December 31 will disappear faster than booze at an office holiday party. 

That's because flex spending accounts, which allow taxpayers to use pretax dollars for out-of-pocket medical expenses, have a "use it or lose it" provision that requires them to use all of the money by the end of the year or watch it disappear. It's the law.

*********************************

1 YEAR: $161,118.95 Gains

This options guru had a perfect record in 2005: He recommended 30 plays and every single one of them saw gains -- totaling a possible $161,118.95... You could join a small group of readers that has already had the chance to reap $1 million in profits...

Read on for details...       

*********************************

So with all of that extra spending going on, I have a new play that has a history of running at year's end: Drugstore.com (DSCM: NASDAQ).

While flex account holders can spend the funds on medical expenses not covered by insurance -- like laser eye surgery, dental expenses, psychiatric care, vaccinations, immunizations and dermatological services, etc. -- they can also spend it on certain over-the-counter medications that can be paid for using the flex spending account, thanks to a September 2003 announcement from the Treasury Department and the IRS:

"Today, the Treasury Department and the IRS announced over-the-counter drugs can be paid for with pre-tax dollars through health care flexible spending accounts. Treasury and IRS issued guidance clarifying that reimbursements for nonprescription drugs by an employer health plan are excluded from income. Thus, reimbursements by health flexible spending arrangements (FSAs) and other employer health plans for the cost of over-the-counter drugs available without prescription are not subject to tax if properly substantiated by the employee."

However, according to Forbes.com, "OTC products are reimbursable if they are used to alleviate or treat personal injuries or sickness and are generally accepted as falling within the category of medicine or drugs." 

Regardless, there are millions of dollars still left in flex spending accounts that must be spent...or they'll disappear forever.

*********************************

Americans Slip Through "Secret Backdoor" to Plunder China's Explosive IPO Market!
 
While Morgan Stanley, Goldman Sachs, and Citibank fight for control of China's sizzling new IPO sector...a small group of conservative investors have discovered a secret backdoor that could make them overnight millionaires.
 
Here's a safe, simple (and ultra-exciting!) way for you to get a piece of the action...without risking one dime overseas!  

*********************************

According to Forbes, Drugstore.com "called upon some of the largest U.S. benefits administrators to create a list of items that are eligible for reimbursement under most plans. On its Web site, Drugstore.com offers some 2,000 OTC items deemed likely to be eligible at its 'FSA Store.' Shoppers can print a detailed receipt to submit to their FSA administrator for reimbursement, and all purchases made throughout the year on the site can be consolidated in a single FSA receipt."

The company, which also places icons next to items on its Web site that are typically eligible for reimbursement, seems to have historically benefited from the spend-it-or-lose-it flex account trend. 

From December 2001 to January 2002, Drugstore.com ran from a low of about 90 cents to about $4.50. From December 2002 to January 2003, the company ran from about $1.75 to about $2.75. From December 2003 to January 2004, it ran from about $5.50 to about $8.  From December 2004 to January 2005, it ran from about $3 to $3.75.  And from December 2005 to January 2006, it ran from about $2.50 to $3.30.

I'm speculating that shares of DSCM could run again from December 2006 to January 2007. A good strategy would be to buy in mid- to late-December, holding until the second week of January. 

Take care,
Ian Cooper

Gunner's Note: You only have six days before this amazing offer expires. Read on to see how you can actually learn this trader's winning "instinct," and how a "No-Talent" trader turned $400 into $200 million...

Ian Cooper is the managing editor and market analyst for the The Taipan Group, the editor of the trading service, Extreme Volatility Speculator, and the free daily e-letter, American Capitalist. Prior to joining the group, Ian practiced as a public relations and marketing consultant, and as a business journalist.

He has written numerous articles for major financial publications, including Taipan and TradersNation.com on topics ranging from trading news, mergers and acquisitions to crude oil, housing, and emerging market opportunities. Cooper has appeared in Investors Business Daily, Forbes.com, Maryland’s Daily Record, and LATimes.com, and has been featured on Money Matters with Barry Armstrong, Stock Dr. with Lee Seiler, and On the Money with Mike Stein. Cooper also contributes to American Venture Magazine, and TradersNation.com, and recently participated in PRNewswire’s Blogs and the Future of Online Media conference in Baltimore, Maryland.

Studying the news dissemination process and Wall Street’s herd mentality of fear gave him a unique perspective that has helped him lead global investors to incredible gains in as little as three hours to six months, despite market direction.